Beaumont Financial Advisors LLC Has $354,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Beaumont Financial Advisors LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 678 shares of the medical equipment provider’s stock after buying an additional 140 shares during the period. Beaumont Financial Advisors LLC’s holdings in Intuitive Surgical were worth $354,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter valued at $38,000. Finally, DT Investment Partners LLC grew its holdings in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on ISRG shares. Piper Sandler restated an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Price Performance

ISRG opened at $610.45 on Thursday. The firm’s fifty day moving average price is $543.14 and its two-hundred day moving average price is $501.89. The company has a market capitalization of $217.43 billion, a price-to-earnings ratio of 98.14, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $614.72.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,487 shares of company stock worth $22,590,975. 0.80% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.